Sagimet Biosciences Inc. Lessee, Operating Lease, Liability, to be Paid, Year One in USD from Q4 2022 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Sagimet Biosciences Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year One history and growth rate from Q4 2022 to Q4 2024.
  • Sagimet Biosciences Inc. Lessee, Operating Lease, Liability, to be Paid, Year One for the quarter ending December 31, 2024 was $80K, a 21.2% increase year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year One, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year One, YoY Quarterly Growth (%)

Sagimet Biosciences Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year One (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 $80K +$14K +21.2% Dec 31, 2024 10-K 2025-03-12
Q4 2023 $66K -$91K -58% Dec 31, 2023 10-K 2024-03-25
Q3 2023 $79K Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $79K Jun 30, 2023 10-Q 2023-08-21
Q4 2022 $157K Dec 31, 2022 10-Q 2023-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.